Assessing diabetes risk
Know more sooner—identify prediabetes and high-risk patients
With our risk panels, you’ll be able to identify more patients with insulin resistance (IR) or prediabetes who are at risk of developing diabetes. Recognizing risk, including hidden risk, earlier, means you can do more sooner to stop or delay the progression to diabetes before it becomes more complex to manage.
Make a difference with our diabetes laboratory test features
Our diabetes risk tests offer key advantages, so you can make a difference when it matters most:
| || |
- Graphical report format—helps you clearly communicate risk to your patients
Learn more about the tests we offer for assessing diabetes risk
We offer a variety of diabetes risk panels to meet the needs of your particular patients and your practice. Choose from the Cardio IQ® Insulin Resistance Panel with Score, the Diabetes Risk Panel with Score, or opt for a panel that also offers insight into cardiovascular risk.
- Cardio IQ® Insulin Resistance Panel with Score
- Cardio IQ® Diabetes Risk Panel with Score
- Diabetes Risk Panel without Score
- Diabetes and ASCVD Risk Panel with Scores
- Cardio IQ® Diabetes and ASCVD Risk Panel with Scores
Let us help you know what’s ahead
Contact a Quest Diagnostics sales representative to learn more
Want to learn more about ADA guidelines-based testing?
View sample report
1 American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Disorders.
The prevention or delay of type 2 diabetes. Diabetes Care. 2002;25:742-749.
2 Genuth S, Kahn R. A step backward—or is it forward? Diabetes Care. 2008;31:1093-1096.
3 Schöttker B, Raum E, Rothenbacher D, et al. Prognostic value of haemoglobin A1c and fasting
plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol. 2011;26:779-787.
4 Sato KK, Hayashi T, Harita N, et al. Combined measurement of fasting plasma glucose and A1c is effective
for the prediction of type 2 diabetes. The Kansai Healthcare Study. Diabetes Care. 2009;32:644-646.
5 Soulimane S, Simon D, Shaw J, et al. HbA1c, fasting plasma glucose and the prediction of
diabetes: Inter99, AusDiab and D.E.S.I.R. Diab Res Clin Pract. 2012;96:392-399.
6 Wang W, Lee ET, Howard BV, et al. Fasting plasma glucose and hemoglobin A1c in identifying
and predicting diabetes. Diabetes Care. 2011;34:363-368.
7 Leong A, Daya N, Porneala B, et al. Prediction of type 2 diabetes by hemoglobin A1c in two
community-based cohorts. Diabetes Care. 2018;41(1):60-68.